Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
Montorsi F, Rosiello G, Gandaglia G. Montorsi F, et al. Among authors: gandaglia g. Eur Urol Oncol. 2024 Apr;7(2):300. doi: 10.1016/j.euo.2023.09.016. Epub 2023 Oct 12. Eur Urol Oncol. 2024. PMID: 37838554 No abstract available.
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A; as part of the EAU-YAU PCa Working Party. Surcel C, et al. Among authors: gandaglia g. World J Urol. 2021 Jul;39(7):2483-2490. doi: 10.1007/s00345-020-03493-5. Epub 2020 Nov 1. World J Urol. 2021. PMID: 33135127
Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36: Let's Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice.
Gómez Rivas J, Gandaglia G, Montorsi F. Gómez Rivas J, et al. Among authors: gandaglia g. Eur Urol Open Sci. 2022 Nov 14;46:135-136. doi: 10.1016/j.euros.2022.09.022. eCollection 2022 Dec. Eur Urol Open Sci. 2022. PMID: 36405303 Free PMC article. No abstract available.
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
Barletta F, Tappero S, Panunzio A, Incesu RB, Cano Garcia C, Piccinelli ML, Tian Z, Gandaglia G, Moschini M, Terrone C, Antonelli A, Tilki D, Chun FKH, De Cobelli O, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Barletta F, et al. Among authors: gandaglia g. Urol Oncol. 2023 Mar;41(3):147.e1-147.e6. doi: 10.1016/j.urolonc.2022.10.027. Epub 2022 Nov 22. Urol Oncol. 2023. PMID: 36428165
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, Beauval JB, Campi R, Minervini A, van den Berg RCN, Soeterik TFW, Zhuang J, Guo H, Gontero P, Montorsi F, Briganti A, Gandaglia G, Ploussard G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Martini A, et al. Among authors: gandaglia g. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):806. doi: 10.1038/s41391-022-00637-z. Prostate Cancer Prostatic Dis. 2023. PMID: 36670304 No abstract available.
Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519-25.
Montorsi F, Barletta F, Gandaglia G. Montorsi F, et al. Among authors: gandaglia g. Eur Urol Oncol. 2023 Aug;6(4):451. doi: 10.1016/j.euo.2023.01.006. Epub 2023 Jan 25. Eur Urol Oncol. 2023. PMID: 36707322 Clinical Trial. No abstract available.
Reply by Authors.
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Briganti A, Montorsi F, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M. Martini A, et al. Among authors: gandaglia g. J Urol. 2023 Jul;210(1):127. doi: 10.1097/JU.0000000000003442.02. Epub 2023 Apr 13. J Urol. 2023. PMID: 37052482 No abstract available.
Re: Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 Guideline.
Gandaglia G, Briganti A, Chiti A, Cozzarini C, Montorsi F. Gandaglia G, et al. Eur Urol Oncol. 2023 May 12:S2588-9311(23)00077-9. doi: 10.1016/j.euo.2023.04.001. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37183078 No abstract available.
Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.
Pellegrino F, Mazzone E, Stabile A, Beauval JB, Marra G, Campi R, Afferi L, Zhuang J, Sorce G, Rosiello G, Barletta F, Scuderi S, Guo H, Gontero P, Minervini A, Ploussard G, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: gandaglia g. Urol Oncol. 2023 Sep;41(9):387.e17-387.e25. doi: 10.1016/j.urolonc.2023.04.019. Epub 2023 May 16. Urol Oncol. 2023. PMID: 37198026
514 results